Biodexa Pharmaceuticals BDRX
NASDAQ BDRX
$0.66 +0.01 (+1.54%)
At close: Sep 30, 2026 · 4:00 PM EDT

Biodexa Pharmaceuticals (BDRX) Prepaid Assets (2018 - 2022)

Updated

Biodexa Pharmaceuticals (BDRX) reported Prepaid Assets of $441,021 for the quarter ended Dec 31, 2022, down 46.1% from $818,242 a year earlier.

Analysis

Biodexa Pharmaceuticals (BDRX) Prepaid Assets (2018 - 2022) Analysis & Trends

As of Dec 31, 2022, Biodexa Pharmaceuticals posted Prepaid Assets of $465,341, down 44.3% from the prior year.

  • Prepaid Assets has a four-year compound annual growth rate of 25.8% (years ended Dec 2018 to Dec 2022).
  • By year, Prepaid Assets came in at $835,159 in the year ended Dec 31, 2021 (+152.1%), $331,310 in the year ended Dec 31, 2020 and $185,643 in the year ended Dec 31, 2018.
  • The figure for the quarter ended Dec 31, 2022 ranks as the lowest quarterly Prepaid Assets since the quarter ended Dec 31, 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Biodexa Pharmaceuticals 41.69 Mn 18.48 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 441,021.05
Dec 31, 2021 818,242.44
Dec 31, 2020 340,676.36
Jun 30, 2019 457,927.29
Dec 31, 2018 178,860.64
API Access

Biodexa Pharmaceuticals Prepaid Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=prepaid-assets&ticker=BDRX&period=max&api_key=YOUR_API_KEY